CTI Foundation is dedicated to preventing and eradicating sickle cell disease, a devastating condition affecting millions worldwide. Through education, awareness campaigns, and partnerships with the healthcare ecosystem, we strive to raise public understanding of sickle cell disease and promote early detection and treatment. We are committed to providing support and resources to individuals and families affected by sickle cell disease while also supporting research efforts to develop new treatments and ultimately find a cure. Together, we can work towards a world where sickle cell disease no longer poses a threat to anyone's health and well-being.
Our idea of a systematic reduction and eventual elimination of the conception of offspring that present with SCD is premised on our vision of a Sickle-Cell-free society, which will forever escape the painful living reality that sickle cell warriors battle with daily and the millions of dollars spent on care and treatment. Our approach is both practical and achievable if we all come together as governments, religious organizations, civil society bodies, and the general public through a public-private partnership model.
Isaac Okello is an outspoken Sickle Cell Advocate, Public Health, and Marketing Officer from Uganda whose advocacy has been marked by the Wego Health Award UK and Outstanding Community Sickle Cell Advocate of the Year US. He launched Raising Hope International Friends (RHIF) in 2016 following the loss of his two cousins, brother and sister, who succumbed to sickle cell in 2016 and 2017, respectively. It was a shock to the entire family, no one had an idea about sickle cell as there was no education, awareness or screening services available.
Following this tragedy in the family, he committed to increase awareness, education and access to screening services for this disorder.
As the Executive Director, Uganda of CTI Foundation, He is committed to accelerating progress towards eradicating sickle cell disease and improving care for affected families and individuals.
Our core values of professionalism, optimism, collaboration, accountability, urgency and persistence will guide our work in support of the 300,000 children born globally with sickle cell each year. Together, we will spearhead innovative solutions and do whatever it takes to positively impact every life affected by sickle cell disease
Intended Use:
Test for qualitative detection of Hemoglobin-S in whole blood using visual check method.
Introduction:
Herrick observed the sickling of erythrocytes from patients with sickle cell anaemia. Since then over 250 structural variants of the haemoglobin molecule have been describe. Itano reported poor solubility of deoxyhaemoglobin-S in concentrate phosphate buffer. Several modifications of the original procedure have been reported.
Copyright © 2024 CTI Foundation- All Rights Reserved
Phone: +256 779 625932
Email: info@ctifoundation.org
